| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $878.4M | +22.1% |
| Cost of Revenue | $631.7M | +26.7% |
| Gross Profit | $246.7M | +11.7% |
| R&D Expense | $6.7M | +31.4% |
| SG&A Expense | $163.0M | +20.7% |
| Operating Income | -$38.5M | -205.5% |
| Pre-tax Income | -$66.3M | -1285.9% |
| Income Tax | -$12.9M | -450.7% |
| Net Income | -$53.5M | -2885.4% |
| EPS (Basic) | -$0.53 | -2750.0% |
| EPS (Diluted) | -$0.53 | -2750.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138.7M | +109.6% |
| Accounts Receivable | $87.7M | +24.0% |
| Inventory | $92.6M | +79.4% |
| Current Assets | $330.9M | +69.5% |
| Total Assets | $1.16B | -1.6% |
| Current Liabilities | $122.2M | +32.4% |
| Long-term Debt | $480.8M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.4M | -3.3% |
| Capital Expenditures | $12.8M | -9.6% |
| Investing Cash Flow | $27.2M | +291.7% |
| Financing Cash Flow | -$78K | +97.9% |
| Free Cash Flow | $32.6M | -0.6% |
| Total Liabilities |
| $682.8M |
| +2.1% |
| Stockholders' Equity | $476.0M | -6.6% |